These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 4464520

  • 41. Blepharospasm and apraxia of eyelid opening associated with anti-Hu paraneoplastic antibodies: a case report.
    Choe CH, Gausas RE.
    Ophthalmology; 2012 Apr; 119(4):865-8. PubMed ID: 22264884
    [Abstract] [Full Text] [Related]

  • 42. Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm.
    Cibis GW, Waeltermann J.
    Mo Med; 1985 Mar; 82(3):145-7. PubMed ID: 3974563
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
    Merello M, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
    [Abstract] [Full Text] [Related]

  • 45. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H.
    J Fr Ophtalmol; 1988 Nov; 11(3):237-40. PubMed ID: 3418019
    [Abstract] [Full Text] [Related]

  • 46. Blepharospasm associated with brainstem lesions.
    Jankovic J, Patel SC.
    Neurology; 1983 Sep; 33(9):1237-40. PubMed ID: 6684264
    [Abstract] [Full Text] [Related]

  • 47. An Oculinum report.
    O'Connor PS.
    J Clin Neuroophthalmol; 1983 Dec; 3(4):227-8. PubMed ID: 6232286
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
    Napolitano A, Bonuccelli U, Rossi B.
    Eur Neurol; 1997 Dec; 38(2):119-22. PubMed ID: 9286635
    [Abstract] [Full Text] [Related]

  • 52. Meige syndrome: treatment with trihexyphenidyl.
    Nutt JG, Hammerstad JP, Carter JH, deGarmo P.
    Adv Neurol; 1983 Dec; 37():201-5. PubMed ID: 6344588
    [No Abstract] [Full Text] [Related]

  • 53. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
    Pourcher E, Bonnet AM, Kefalos J, Dubois B, Agid Y.
    Mov Disord; 1989 Dec; 4(3):195-201. PubMed ID: 2779590
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Open multicenter trial with Madopar HBS in parkinsonian patients. Preliminary assessment after short-term treatment.
    Jansen EN, Meerwaldt JD, Heersema T, van Manen J, Speelman JD.
    Eur Neurol; 1987 Dec; 27 Suppl 1():88-92. PubMed ID: 3322841
    [Abstract] [Full Text] [Related]

  • 56. Levodopa, manganese, and degenerations of the brain.
    Cotzias GC.
    Harvey Lect; 1974 Dec; 68():115-47. PubMed ID: 4452625
    [No Abstract] [Full Text] [Related]

  • 57. Evaluation of chronic levodopa therapy in Parkinson's disease.
    Battistin L, Bracco F, Saladini M.
    J Neural Transm Suppl; 1986 Dec; 22():201-7. PubMed ID: 3465871
    [Abstract] [Full Text] [Related]

  • 58. [Dementia--Parkinson disease: role of antiglutamatergic drugs. Symposium: 4 April, Hamburg].
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6 Suppl Demenz Mor):1-6. PubMed ID: 9696997
    [No Abstract] [Full Text] [Related]

  • 59. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD, Ismail HA, Frank C.
    Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
    [No Abstract] [Full Text] [Related]

  • 60. [Blepharospasm treatment with botulinum toxin (follow-up)].
    Roggenkämper P.
    Klin Monbl Augenheilkd; 1986 Oct; 189(4):283-5. PubMed ID: 3807220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.